SCHEMBL3989913

SCHEMBL3989913

O=C(NCc1ccccc1)N1CC2CC1CN2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MC4R P32245 2/20 0.48
HRH3 Q9Y5N1 2/20 0.46
ITGB1 P05556 1/20 0.46
ITGA5 P08648 1/20 0.46
CHRNB2 P17787 1/20 0.46
CHRNA3 P32297 1/20 0.46
CHRNA4 P43681 1/20 0.46
CHRNB3 Q05901 1/20 0.46
CHRNA6 Q15825 1/20 0.46
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
MAPK1 P28482 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
PARP1 P09874 1/20 0.45
CACNA1G O43497 3/20 0.45
CACNA1H O95180 3/20 0.45
CACNA1I Q9P0X4 3/20 0.45
GAA P10253 1/20 0.44
DPP4 P27487 1/20 0.44
FKBP1A P62942 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30916976 0.79 CHRNB2 (0.49) CHRNB2CHRNA3CHRNA4CHRNB3CHRNA6
SCHEMBL3990079 0.79 MEN1 (0.51) HRH3ITGB1ITGA5MEN1KMT2A
SCHEMBL286830 0.76 HTR2C (0.51) CHRNB2CHRNA3CHRNA4CHRNB3CHRNA6
SCHEMBL15409979 0.76 HTR2C (0.51) CHRNB2CHRNA3CHRNA4CHRNB3CHRNA6
SCHEMBL30879640 0.74 CHRNB2 (0.50) CHRNB2CHRNA3CHRNA4CHRNB3CHRNA6
SCHEMBL14211340 0.74 NPSR1 (0.56) MC4RHRH3CHRNA3MEN1KMT2A
SCHEMBL8007264 0.74 PREP (0.53) MEN1KMT2AGAA
SCHEMBL3528872 0.74 CHRNB2 (0.53) CHRNB2CHRNA3CHRNA4CHRNB3CHRNA6
SCHEMBL4697348 0.72 CHRNB2 (0.48) CHRNB2CHRNA3CHRNA4CHRNB3CHRNA6
SCHEMBL24028170 0.71 CHRNB2 (0.47) CHRNB2CHRNA3CHRNA4CHRNB3CHRNA6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009063364-A2 MODULATORS OF UROTENSIN RECEPTOR AND METHODS OF USE THEREOF ENCYSIVE PHARMACEUTICALS INC. (US) 2009-05-22 WO disclosed